Sero-monitoring of health care workers reveals complex relationships between common coronavirus antibodies and SARS-CoV-2 severity
Madison E. Weirick,
Marcus J Bolton,
Claudia P Arevalo,
Eileen C. Goodwin,
Elizabeth M Anderson,
Christopher M. McAllister,
Shannon R. Christensen,
Daniel J Rader,
E John Wherry,
Scott E. Hensley
Posted 19 Apr 2021
medRxiv DOI: 10.1101/2021.04.12.21255324
Posted 19 Apr 2021
Recent common coronavirus (CCV) infections are associated with reduced COVID-19 severity upon SARS-CoV-2 infection, however the immunological mechanisms involved are unknown. We completed serological assays using samples collected from health care workers to identify antibody types associated with SARS-CoV-2 protection and COVID-19 severity. Rare SARS-CoV-2 cross-reactive antibodies elicited by past CCV infections were not associated with protection; however, the duration of symptoms following SARS-CoV-2 infections was significantly reduced in individuals with higher common betacoronavirus (betaCoV) antibody titers. Since antibody titers decline over time after CCV infections, individuals in our cohort with higher betaCoV antibody titers were more likely recently infected with common betaCoVs compared to individuals with lower antibody titers. Therefore, our data suggest that recent betaCoV infections potentially limit the severity of SARS-CoV-2 infections through mechanisms that do not involve cross-reactive antibodies. Our data are consistent with the emerging hypothesis that cellular immune responses elicited by recent common betaCoV infections transiently reduce disease severity following SARS-CoV-2 infections.
- Downloaded 1,378 times
- Download rankings, all-time:
- Site-wide: 16,444
- In infectious diseases: 1,823
- Year to date:
- Site-wide: 2,767
- Since beginning of last month:
- Site-wide: 14,545
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!